Latest Breaking News On - Iocon subsidiary - Page 1 : comparemela.com

The company stated that there is no cash consideration involved but BBL will issue and allot 15 per cent equity shares to Serum on a fully diluted basis, subject to necessary approvals and sanctions.

Adar poonawallaBiocon biologics ltdBiocon limited onSerum institute life sciences privateCovidshield technologies pvt ltdSerum institute of indiaBiocon limitedSerum instituteSerum institute life sciences private limitedSerum institute of indiaBiocon biologicsCovidshield technologies pvt ltdIocon subsidiaryErum subsidiaryIocon serum subsidiaries merger